| Cost of disorders of the brain in Europe 2010 A Gustavsson, M Svensson, F Jacobi, C Allgulander, J Alonso, E Beghi, ... European neuropsychopharmacology 21 (10), 718-779, 2011 | 2262 | 2011 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1776 | 2016 |
| The worldwide costs of dementia 2015 and comparisons with 2010 A Wimo, M Guerchet, GC Ali, YT Wu, AM Prina, B Winblad, L Jönsson, ... Alzheimer's & Dementia 13 (1), 1-7, 2017 | 1161 | 2017 |
| The worldwide economic impact of dementia 2010 A Wimo, L Jönsson, J Bond, M Prince, B Winblad, AD International Alzheimer's & dementia 9 (1), 1-11. e3, 2013 | 1146 | 2013 |
| The worldwide societal costs of dementia: Estimates for 2009 A Wimo, B Winblad, L Jönsson Alzheimer's & Dementia 6 (2), 98-103, 2010 | 630 | 2010 |
| An estimate of the total worldwide societal costs of dementia in 2005 A Wimo, B Winblad, L Jönsson Alzheimer's & Dementia 3 (2), 81-91, 2007 | 413 | 2007 |
| Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study MJL Graff, EMM Adang, MJM Vernooij-Dassen, J Dekker, L Jönsson, ... Bmj 336 (7636), 134-138, 2008 | 376 | 2008 |
| The economic impact of dementia in Europe in 2008—cost estimates from the Eurocode project A Wimo, L Jönsson, A Gustavsson, D McDaid, K Ersek, J Georges, ... International journal of geriatric psychiatry 26 (8), 825-832, 2011 | 305 | 2011 |
| Burden of illness of chronic low back pain in Sweden: a cross-sectional, retrospective study in primary care setting M Ekman, S Jönhagen, E Hunsche, L Jönsson Spine 30 (15), 1777-1785, 2005 | 299 | 2005 |
| Determinants of costs of care for patients with Alzheimer's disease L Jönsson, ME Jönhagen, L Kilander, H Soininen, M Hallikainen, ... International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2006 | 294 | 2006 |
| The cost of dementia in Europe: a review of the evidence, and methodological considerations L Jönsson, A Wimo Pharmacoeconomics 27, 391-403, 2009 | 265* | 2009 |
| Alzheimer disease international A Wimo, L Jönsson, J Bond, M Prince, B Winblad The worldwide economic impact of dementia, 1-11, 2010 | 244 | 2010 |
| Economic consequences of the progression of rheumatoid arthritis in Sweden G Kobelt, K Eberhardt, L Jönsson, B Jönsson Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 226 | 1999 |
| The cost‐effectiveness of infliximab (Remicade®) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study G Kobelt, L Jönsson, A Young, K Eberhardt Rheumatology 42 (2), 326-335, 2003 | 210 | 2003 |
| The economic and quality of life impact of hypoglycemia J Lundkvist, C Berne, B Bolinder, L Jönsson The European journal of health economics 6, 197-202, 2005 | 209 | 2005 |
| Patient-and proxy-reported utility in Alzheimer disease using the EuroQoL L Jönsson, N Andreasen, L Kilander, H Soininen, G Waldemar, ... Alzheimer Disease & Associated Disorders 20 (1), 49-55, 2006 | 192 | 2006 |
| Application of Resource Utilization in Dementia (RUD) instrument in a global setting A Wimo, A Gustavsson, L Jönsson, B Winblad, MA Hsu, B Gannon Alzheimer's & dementia 9 (4), 429-435. e17, 2013 | 186 | 2013 |
| Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease F Boström, L Jönsson, L Minthon, E Londos Alzheimer Disease & Associated Disorders 21 (2), 150-154, 2007 | 182 | 2007 |
| Predictors of costs of care in Alzheimer’s disease: a multinational sample of 1222 patients A Gustavsson, P Brinck, N Bergvall, K Kolasa, A Wimo, B Winblad, ... Alzheimer's & Dementia 7 (3), 318-327, 2011 | 170 | 2011 |
| Cost effectiveness of alendronate (Fosamax®) for the treatment of osteoporosis and prevention of fractures O Johnell, B Jönsson, L Jönsson, D Black Pharmacoeconomics 21, 305-314, 2003 | 164 | 2003 |
